References
- Massague J. The transforming growth factor beta family. Ann Rev Cell Biol 1990;6:597–641
- Ying S-Y. Inhibins, activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. End ocr Rev 1988;9:267–93
- Qu J, Thomas K. Inhibin and activin production in human placenta. End ocr Rev 1995;16:485–507
- Petraglia F, De Vita D, Gallinelli A, et al. Abnormal concen-tration of maternal serum activin-A in gestational diseases. J Clin End ocrinol Metab 1995;80:558–61
- Petraglia F, Aguzzoli L, Gallinelli A, et al. Hypertension in pregnancy: changes in activin A maternal serum concen-tration. Placenta 1995;16:447–54
- Muttukrishna S, Knight PG, Groome NP, et al. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997;349:1285–8
- Silver HM, Lambert-Messerlian GM, Star JA, et al. Compari-son of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999;180:1131–7
- Laivuori H, Kaaj a R, Turpeinen U, et al. Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity. Br J Obstet Gynaecol 1999;106:1298–303
- D'Antona D, Reis FM, Benedetto C, et al. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J Endocrinol 2000;165:157–62
- Multuhrishna S, North RA, Morris J, et al. Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000;15:1640–5
- Florio P, Reis FM, Rezzari I, et al. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2003;21:165–9
- Keelan JA, Taylor R, Schellenberg JC, et al. Serum activin A, inhibin A and follistatin concentrations in pre-eclampsia or small for gestational age pregnancies. Obstet Gynecol 2002;99:267–74
- Davidson EJ, Riley SC, Roberts SA, et al. Maternal serum activin, inhibin, human chorionic gonadotrophin and a-fetoprotein as second trimester predictors of pre-eclampsia. Br J Obstet Gynaecol 2003;110:46–52
- Wallace EM, Schneider-Kolsky ME, Edwards A, et al. Maternal serum activin A levels in association with intra-uterine fetal growth restriction. Br J Obstet Gynaecol 2003; 110:306–10
- Keelan JA, Taylor R, Schellenberg JC, et al. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstet Gynecol 2002; 99:267–74
- Genbacev O, Joslin R, Damsky CH, et al. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996;97:540–50
- Pijnenborg R, Anthony J, Davey DA, etal. Placental bed spiral arteries in the hypertensive disorders of pregnancy. BrJ Obstet Gynaecol 1991;98:648–55
- Khong TY, De Wolf F, Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049–59
- Papageorghiou AT, Yu CKH, Bindra R, et al. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441�9
- Martin AM, Bindra R, Curcio P, et al. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler at 11�14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583�6
- Spencer K, Souter V, Tul N, et al. A screening programme for trisomy 21 at 10�14 weeks using fetal nuchal translucency, maternal serum free � human chorionic gonadotropin and pregnancy associated plasma protein A. Ultrasound Obstet Gynecol 1999;13:231�7
- Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. AmJ Obstet Gynecol 1988;158:892�8
- Yudkin PL, Aboualfa M, Eyre JA, et al. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987; 15:45–52
- Engelese MA, Neele JM, van Achterberg TA, et al. Human activin-A is expressed in the atherosclerotic lesion and promotes the contractile phenotype of smooth muscle cells. Circ Res 1999;85:931–9
- Brown MR, Vaughan J, Jimenez LL, et al Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology 1991;129:2355–60
- Nusing RM., Barsig J. Induction of prostanoid, nitric oxide and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol 1999;127:919–26